![](/img/cover-not-exists.png)
Additional bevacizumab in EGFR-mutant lung adenocarcinoma patients who had oligo-progression after the failure of EGFR-TKI: A single-institute retrospective study
Kashiwabara, Kosuke, Fujii, Shinji, Tsumura, Shinsuke, Sakamoto, Kazuhiko, Semba, HiroshiVolume:
22
Year:
2020
Language:
english
Journal:
Cancer Treatment and Research Communications
DOI:
10.1016/j.ctarc.2019.100163
File:
PDF, 530 KB
english, 2020